NASDAQ · Analyst Forecast

Decoy Therapeutics Inc. (DCOY) Stock Forecast & Price Target

$0.95 NASDAQ: DCOY Market Cap $505050

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Decoy Therapeutics Inc. (DCOY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Decoy Therapeutics Inc., the average estimate for 2028 earnings per share is −$16.49; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$0$0$01
2025$0$0$01
2026$11.88M$11.88M$11.88M1
2027$0$0$01
2028$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2024−$727.20−$727.20−$727.201
2025−$57.95−$57.95−$57.951
2026−$11.34−$11.34−$11.341
2027−$9.46−$9.46−$9.461
2028−$16.49−$16.49−$16.491

Decoy Therapeutics Inc. (DCOY) forecast — frequently asked questions

What are analysts forecasting for Decoy Therapeutics Inc.'s earnings?

The average analyst estimate for Decoy Therapeutics Inc. (DCOY) earnings per share in 2028 is -16.49, with individual estimates between -16.49 and -16.49.

How much revenue is Decoy Therapeutics Inc. expected to make?

Analysts forecast Decoy Therapeutics Inc. (DCOY) revenue of $0 in 2028, based on 1 published estimates.

How many analysts cover DCOY?

1 analyst contribute estimates for Decoy Therapeutics Inc. (DCOY). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.